Tag - dementia



The new Alzheimer's drug lecanemab, branded Leqembi
Dec 13, 2023
New Alzheimer's drug to be covered by health insurance in Japan
The drug, to be launched Dec. 20, will cost around ¥2.98 million per year in Japan but patients will only have to pay a limited share.
A research has found that hexaraphane — a component found in wasabi — helps improve the episodic and working memories of elderly people.
JAPAN / Science & Health
Nov 26, 2023
Wasabi effective in improving memory of elderly: study
In addition to known antioxidant and anti-inflammatory effects, new research indicates improvements in episodic and working memories.
AI software is being used to detect cognitive decline in older Japanese drivers in order to help prevent accidents.
Oct 22, 2023
AI startup helps insurers spot cognitive decline in elderly drivers
Once reliant on a driver's age and model of car, some insurers now rely on AI to expedite settlements and craft more precise risk assessments.
Elderly people experience taking part in esports in Ono, Fukushima Prefecture.
JAPAN / Science & Health / Regional Voices: Fukushima
Oct 16, 2023
Fukushima town turns to esports as a health tool for the elderly
Ono and Fukushima Medical University have been holding trial sessions and analyzing the effects of gaming experience on cognitive functions.
A 93-year-old at his office in Tokyo solves ancient math problems in Egyptian numbers to keep his mind sharp.
JAPAN / Science & Health
Oct 3, 2023
Japan prepares national project to deal with dementia
About 9.53 million people, or 1 in 4 elderly people, are predicted to have dementia in 2040.
An elderly person plays a racing video game in 2022 to ward off dementia.
JAPAN / Science & Health
Sep 25, 2023
As Japan OKs Alzheimer's drug, issue of side effects comes into focus
There are big challenges ahead for the use of lecanemab, particularly on how to control side effects such as brain swelling and bleeding.
Shinobu Yamanaka, a mom of three sons and director of a day care facility in Konan, Kochi Prefecture, serves up to eight "members" six days a week.
JAPAN / Science & Health / FOCUS
Aug 22, 2023
Kochi dementia care center aims to set new paradigm in Japan
A new generation of people with Alzheimer’s in Japan are trying to change not only dementia care but also social attitudes toward patients.
Packages of lecanemab, marketed as Leqembi, for the U.S. market
JAPAN / Science & Health
Aug 21, 2023
Japanese ministry panel gives OK to Alzheimer’s drug lecanemab
The panel’s endorsement will be followed by official approval by the health minister in coming days.
Japan Times
WORLD / Science & Health
Jul 17, 2023
Alzheimer's diagnosis revamp embraces rating scale similar to cancer
New guidelines would replace terminology such as mild, moderate and severe, instead using a numerical system related to disease progression.
Japan Times
BUSINESS / Companies
Jul 11, 2023
Eisai appoints CEO’s son to lead global Alzheimer drug program
Eisai's former global Alzheimer drug program officer, who led the push for U.S. approval of breakthrough medicine Leqembi, will retire at the end of the month.
Japan Times
WORLD / Science & Health
Jul 7, 2023
Eisai Alzheimer's drug gets full U.S. approval, widening access to the therapy
The broader clearance from the Food and Drug Administration marks a milestone for treatment of the dementia that afflicts some 6 million Americans.
Japan Times
JAPAN / Science & Health / FOCUS
Jul 4, 2023
Expectations grow for Alzheimer's drug in Japan, but hurdles remain
Lecanemab could be approved in the country as early as fall, but more specialist doctors and a patient screening system would be needed for widespread use.
Japan Times
Jul 3, 2023
Can we cure dementia before it starts?
Octogenarian and biologist Leroy Hood is trying to make the Elizabeth Holmes-ian dream of preventive medicine come true.
Japan Times
JAPAN / Society
Jun 22, 2023
Dementia-related missing person cases doubled over past 10 years
A total of 18,709 people with dementia were reported missing in 2022, up 6.1% from the previous year.
Japan Times
WORLD / Science & Health
Jun 19, 2023
New Eisai and Biogen Alzheimer drug faces hurdles in Europe
Some doctors said its effect on the disease may not be clinically meaningful enough when weighed against the risk of brain swelling, its likely high price.
Japan Times
JAPAN / Science & Health
Jun 15, 2023
Parliament passes law aimed at supporting people with dementia
The health ministry expects the number of people with dementia in Japan to reach 7 million by 2025.
Japan Times
Jun 1, 2023
Obesity and Alzheimer's news makes Eli Lilly world’s most valuable drugmaker
An 8.5% gain in May for Eli Lilly lifted its shares to a record high, while displaced Johnson & Johnson slumped 5.3% during the month.
Japan Times
May 17, 2023
A breakthrough on Alzheimer's is closer than ever
Promising data could open the door to insurance coverage for expensive new Alzheimer's drugs, bringing them closer to patients.
Japan Times
WORLD / Science & Health
Apr 6, 2023
Air pollution linked to increased dementia risk, Harvard researchers find
The World Health Organization recommends that average annual PM2.5 levels be below 5 micrograms — but nearly the entire global population breathes air that exceeds those limits.
Japan Times
Jan 19, 2023
Asia turns to tech to help watch over a growing elderly population
Smart home technologies such as cameras, robots, motion sensors and artificial intelligence-based speakers are being rolled out to help take care of loved ones.


Yayoi Kusama’s “Pumpkin,” once the victim of high waves that dragged it into the sea, sits at the end of a pier on the south side of Naoshima.
Why is the most exciting art in Japan so hard to get to?